Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 2 , Pages 119-120 , February 2008

Conflict of Interest

,Accepted 16 August 2007.

REFERENCES 

  1. Lewis DA , Michels R , Pine DS , et al.   Conflict of interest . Am J Psychiatry . 2006;163:571–573
  2. International Committee of Medical Journal Editors  . Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication . www.icmje.org Accessed March 31, 2007.
  3. Flanagin A , Fontanarosa PB , DeAngelis CD . Update on JAMA's conflict of interest policy . JAMA . 2006;296:220–221
  4. DeAngelis CD , Fontanarosa PB . Unreported financial disclosures in a study of migraine and cardiovascular disease . JAMA . 2006;296:654
  5. Council of Science Editors  . CSE's white paper on promoting integrity in scientific journal publications . www.CouncilScienceEditors.org Accessed August 10, 2007

 Disclosure: Dr. Faraone receives research support from, is on the speakers' bureaus of, and has had an advisory or consulting relationship with McNeil Pediatrics and Shire Laboratories; he has also had an advisory or consulting relationship with Novartis and Eli Lilly. Dr. Stein receives grant/research support from Pfizer. Dr. Walkup receives grants/research support from Eli Lilly, Pfizer, and Abbott; is a consultant to Eli Lilly, Pfizer, Jazz, and Cephalon; and has received honoraria from and been on the speakers' bureaus of Eli Lilly and Pfizer. Drs. Martin, Henderson, Hudziak, Leibenluft, Piacentini, and Todd report no conflicts of interest.

PII: S0890-8567(09)62279-6

doi: 10.1097/chi.0b013e31815d6dba

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 2 , Pages 119-120 , February 2008

Article Tools